The Food and Drug Administration is expanding approval of leucovorin to treat an ultra-rare genetic condition.

The Food and Drug Administation is approving a generic drug for a very rare genetic disorder, but not for autism.

It's a major step back from statements made at a White House news conference in September, when President Donald Trump and ...

The FDA has approved a generic drug for a very rare brain disorder, while walking back suggestions by Trump it showed promise for people with autism. (AP Photo) ...

Drug's approval expanded, but only to patients with genetic cerebral folate transport defi ...

The agency said it approved leucovorin for children and adults with a genetic condition that limits delivery of folate, a form of vitamin B, to the brain. FDA officials estimate the ultrarare ...

Researchers at the University of California San Diego have identified new genetic variants associated with autism spectrum disorder (ASD) by using long-read whole genome sequencing (LR-WGS), an ...

In September, Trump and the FDA commissioner announced the drug was under review to benefit patients with autism. The FDA didn't find evidence of that.

The Food and Drug Administration on Tuesday approved a generic medication for a rare brain disorder, while walking back suggestions by President Donald Trump and other administration officials that ...

What is leucovorin? FDA expands drug’s approved use but walks back autism claims - Unresolved questions about the drug haven’t stopped U.S. doctors from prescribing it ...

A Rothbardian view of vaccines and society is that no government should have the power to coerce someone into having a vaccine. Their safety is irrelevant for ...